Summary
The Scripps Research Institute (TSRI) is a research and educational organization which conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The organization offers technology and scientific services such as antibody development and production, cell based screening, high performance computing, normal blood donor service and murine behavioral assessment, among others. TSRI also offers education services that include undergraduate, graduate and postdoctoral programs. Its research centers and institutes include Integrative Molecular Biosciences, Center for Metabolomics, Dorris Neuroscience Center, Molecular Screening Center, and others. TSRI is headquartered in La Jolla, California, the US.
The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
The Scripps Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10
The Scripps Research Institute, Medical Devices Deals, 2010 to YTD 2016 11
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 12
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deal Details 16
Partnerships 16
Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 16
Yisheng Biopharma Enters into Research Agreement with The Scripps Research Institute 17
Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 18
Scripps Research Institute, ZIP and IME Enter into Partnership 20
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 21
Serina Therapeutics Enters Into Research Agreement With Scripps Research Institute 23
Scripps Research Institute Expands Research Agreement With Takeda 24
Proteostasis Therapeutics Enters Into Co-Development Agreement With Scripps Research Institute 26
Scripps Research Institute Enters Into Research Agreement With Bristol-Myers Squibb 28
ChromaDex Enters Into Co-Development Agreement With Scripps Research Institute 29
Jupiter Medical Center Enters Into Research Agreement With The Scripps Research Institute 30
LEO Pharma Enters Into Research Collaboration With The Scripps Research Institute 31
Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 32
Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 33
Envoy Therapeutics Expands Its Research Agreement With The Scripps Research Institute 34
Envoy Therapeutics Enters Into Research Collaboration With Scripps Research 35
Sorrento Therapeutics Enters Into Co-Development Agreement With The Scripps Research Institute 36
Licensing Agreements 37
BlinkBio Enters into Option agreement with Scripps Research Institute 37
iGenomX Enters into Licensing Agreement with Scripps Research Institute 38
OPKO Health Enters into Licensing Agreement with Scripps Research Institute 39
Corvus Pharma Enters into Licensing Agreement with Scripps Research Institute 40
Padlock Therapeutics Enters into Licensing Agreement with Scripps Research Institute 42
Fabrus Enters into Licensing Agreement with Scripps Research Institute 43
Scripps Research Institute Enters into Licensing Agreement with T23 Biopharma for CD22 44
Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 45
Zebra Biologics Enters into Licensing Agreement with Scripps Research Institute 47
Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute 48
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 50
Janssen Pharma Enters Into Licensing Agreement With Scripps Research Institute For Infectious Diseases 52
Serina Therapeutics Enters Into License Agreement With Scripps Research Institute For Click Chemistry 53
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 54
OPKO Health Enters Into Licensing Agreement With Scripps Research Institute For SR 3306 55
Integrated Diagnostics Enters Into Licensing Agreement With The Scripps Research Institute 56
Scripps Research Enters Into Licensing Agreement With Aileron Therapeutics 57
Allozyne Enters Into Licensing Agreement With The Scripps Research Institute 58
Equity Offering 59
Blackthorn Therapeutics Spin Off from Scripps Research Institute 59
The Scripps Research Institute - Key Competitors 60
Key Employees 61
Locations And Subsidiaries 62
Head Office 62
Other Locations & Subsidiaries 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63
List of Tables
The Scripps Research Institute, Pharmaceuticals & Healthcare, Key Facts 1
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
The Scripps Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
The Scripps Research Institute, Deals By Therapy Area, 2010 to YTD 2016 10
The Scripps Research Institute, Medical Devices Deals, 2010 to YTD 2016 11
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 12
Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 16
Yisheng Biopharma Enters into Research Agreement with The Scripps Research Institute 17
Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 18
Scripps Research Institute, ZIP and IME Enter into Partnership 20
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 21
Serina Therapeutics Enters Into Research Agreement With Scripps Research Institute 23
Scripps Research Institute Expands Research Agreement With Takeda 24
Proteostasis Therapeutics Enters Into Co-Development Agreement With Scripps Research Institute 26
Scripps Research Institute Enters Into Research Agreement With Bristol-Myers Squibb 28
ChromaDex Enters Into Co-Development Agreement With Scripps Research Institute 29
Jupiter Medical Center Enters Into Research Agreement With The Scripps Research Institute 30
LEO Pharma Enters Into Research Collaboration With The Scripps Research Institute 31
Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 32
Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 33
Envoy Therapeutics Expands Its Research Agreement With The Scripps Research Institute 34
Envoy Therapeutics Enters Into Research Collaboration With Scripps Research 35
Sorrento Therapeutics Enters Into Co-Development Agreement With The Scripps Research Institute 36
BlinkBio Enters into Option agreement with Scripps Research Institute 37
iGenomX Enters into Licensing Agreement with Scripps Research Institute 38
OPKO Health Enters into Licensing Agreement with Scripps Research Institute 39
Corvus Pharma Enters into Licensing Agreement with Scripps Research Institute 40
Padlock Therapeutics Enters into Licensing Agreement with Scripps Research Institute 42
Fabrus Enters into Licensing Agreement with Scripps Research Institute 43
Scripps Research Institute Enters into Licensing Agreement with T23 Biopharma for CD22 44
Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 45
Zebra Biologics Enters into Licensing Agreement with Scripps Research Institute 47
Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute 48
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 50
Janssen Pharma Enters Into Licensing Agreement With Scripps Research Institute For Infectious Diseases 52
Serina Therapeutics Enters Into License Agreement With Scripps Research Institute For Click Chemistry 53
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 54
OPKO Health Enters Into Licensing Agreement With Scripps Research Institute For SR 3306 55
Integrated Diagnostics Enters Into Licensing Agreement With The Scripps Research Institute 56
Scripps Research Enters Into Licensing Agreement With Aileron Therapeutics 57
Allozyne Enters Into Licensing Agreement With The Scripps Research Institute 58
Blackthorn Therapeutics Spin Off from Scripps Research Institute 59
The Scripps Research Institute, Key Competitors 60
The Scripps Research Institute, Key Employees 61
The Scripps Research Institute, Other Locations 62
The Scripps Research Institute, Subsidiaries 62
List of Figures
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 8
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10
The Scripps Research Institute, Medical Devices Deals, 2010 to YTD 2016 11
